dalteparin has been researched along with Craniocerebral Injuries in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilge, A | 1 |
| Gunes, A | 1 |
| Dagli, M | 1 |
| Koybasioglu, FF | 1 |
| Guvey, A | 1 |
| Pikis, S | 1 |
| Moscovici, S | 1 |
| Itshayek, E | 1 |
| Cohen, JE | 1 |
2 other studies available for dalteparin and Craniocerebral Injuries
| Article | Year |
|---|---|
The impact of topical and systemic enoxaparin sodium use on traumatic tympanic membrane perforation and myringosclerosis.
Topics: Administration, Topical; Animals; Anticoagulants; Craniocerebral Trauma; Enoxaparin; Injections, Sub | 2016 |
Cerebral sinodural thrombosis following minor head injury in children.
Topics: Accidental Falls; Accidents, Traffic; Adolescent; Anticoagulants; Cerebral Angiography; Child; Child | 2013 |